HK1248102A1 - 三脈衝釋放興奮劑製劑 - Google Patents
三脈衝釋放興奮劑製劑Info
- Publication number
- HK1248102A1 HK1248102A1 HK18107473.1A HK18107473A HK1248102A1 HK 1248102 A1 HK1248102 A1 HK 1248102A1 HK 18107473 A HK18107473 A HK 18107473A HK 1248102 A1 HK1248102 A1 HK 1248102A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- tripulse
- release stimulant
- formulations
- stimulant formulations
- release
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Psychology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562121537P | 2015-02-27 | 2015-02-27 | |
| PCT/US2016/019877 WO2016138440A1 (en) | 2015-02-27 | 2016-02-26 | Tripulse release stimulant formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1248102A1 true HK1248102A1 (zh) | 2018-10-12 |
Family
ID=56789928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18107473.1A HK1248102A1 (zh) | 2015-02-27 | 2018-06-08 | 三脈衝釋放興奮劑製劑 |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US20160250148A1 (zh) |
| EP (1) | EP3261625A4 (zh) |
| JP (2) | JP2018506590A (zh) |
| KR (2) | KR20170134409A (zh) |
| CN (1) | CN107530289A (zh) |
| AU (2) | AU2016225052B2 (zh) |
| BR (1) | BR112017018322A2 (zh) |
| CA (1) | CA2977540C (zh) |
| HK (1) | HK1248102A1 (zh) |
| IL (1) | IL254159B2 (zh) |
| MX (1) | MX2017011005A (zh) |
| WO (1) | WO2016138440A1 (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021197376A1 (zh) * | 2020-03-31 | 2021-10-07 | 江苏恒瑞医药股份有限公司 | 一种非布司他片 |
| WO2022240849A1 (en) * | 2021-05-11 | 2022-11-17 | Cingulate Therapeutics LLC | Trimodal, precision-timed pulsatile release tablet |
| WO2023158694A1 (en) * | 2022-02-16 | 2023-08-24 | Cingulate Therapeutics LLC | Trimodal, precision-timed release tablet |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3131402A1 (de) | 1981-08-07 | 1983-02-24 | Kilian & Co GmbH, 5000 Köln | Verfahren und tablettenpresse zum aufeinanderfolgenden herstellen einer vielzahl von tabletten mit gleichem gewicht |
| DE3404108A1 (de) | 1984-02-07 | 1985-08-14 | Kilian & Co GmbH, 5000 Köln | Tablettenpresse |
| DE9306785U1 (zh) | 1993-05-05 | 1993-07-08 | Kilian & Co. Gmbh Maschinenfabrik, 5000 Koeln, De | |
| ES2178078T3 (es) | 1997-07-23 | 2002-12-16 | Kilian Gmbh & Co Kg | Prensa de comprimidos con marcha concentrica. |
| US20010055613A1 (en) * | 1998-10-21 | 2001-12-27 | Beth A. Burnside | Oral pulsed dose drug delivery system |
| EP1191924A4 (en) * | 1999-04-06 | 2005-02-09 | Pharmaquest Ltd | PHARMACEUTICAL PHARMACEUTICAL FORM FOR PULSED ADMINISTRATION OF (D-THREO) METHYLPHENIDATE AND ANOTHER CNS STIMULATING SUBSTANCE |
| US20030170181A1 (en) | 1999-04-06 | 2003-09-11 | Midha Kamal K. | Method for preventing abuse of methylphenidate |
| DK1302304T3 (da) | 2000-06-20 | 2012-03-26 | Sanwa Kagaku Kenkyusho Co | Fremgangsmåde til fremstilling af en kernepresset artikel |
| JP2004501190A (ja) * | 2000-06-23 | 2004-01-15 | テバ ファーマシューティカル インダストリーズ リミティド | 治療薬の胃部保留および制御された放出のための急速膨張する組成物とその組成物を含む剤形 |
| ATE418956T1 (de) | 2001-09-26 | 2009-01-15 | Sanwa Kagaku Kenkyusho Co | Verfahren und vorrichtung zur herstellung eines mehrkernigen geformten artikels |
| JP4248225B2 (ja) | 2002-11-01 | 2009-04-02 | トヨタ自動車株式会社 | 燃料電池システム |
| CN100410063C (zh) | 2003-11-14 | 2008-08-13 | 株式会社三和化学研究所 | 有核成型品的制造方法 |
| DK1782944T3 (da) | 2004-08-26 | 2014-09-01 | Kikusui Seisakusho Ltd | Maskine til formning med rotationskompression, som anvender et stempel |
| DE202005001556U1 (de) | 2005-01-31 | 2006-03-16 | Kilian Gmbh & Co. Kg | Matritzenscheibe für Rundlauf-Tablettepresse und Rundlauf-Tablettenpresse |
| CA2651890C (en) * | 2006-05-12 | 2015-01-27 | Shire Llc | Controlled dose drug delivery system |
| DE202007002707U1 (de) | 2007-02-21 | 2008-07-03 | Ima Kilian Gmbh & Co.Kg | Füllschuh für Rotationstablettenpressen |
| CA2678806C (en) * | 2007-02-21 | 2017-05-16 | Connected Health Systems, Llc | Treating adhd and other diseases involving inflammation |
| CN101888828A (zh) * | 2007-07-27 | 2010-11-17 | 蒂宝制药公司 | 脉冲胃滞留剂型 |
| AU2009311877C1 (en) * | 2008-11-07 | 2013-08-15 | Samyang Holdings Corporation | Pharmaceutical composition for release control of methylphenidate |
| GB201003731D0 (en) | 2010-03-05 | 2010-04-21 | Univ Strathclyde | Immediate/delayed drug delivery |
| GB201003766D0 (en) | 2010-03-05 | 2010-04-21 | Univ Strathclyde | Pulsatile drug release |
| GB201003734D0 (en) | 2010-03-05 | 2010-04-21 | Univ Strathclyde | Delayed prolonged drug delivery |
| CA2902911C (en) * | 2014-10-31 | 2017-06-27 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
-
2016
- 2016-02-26 US US15/054,934 patent/US20160250148A1/en not_active Abandoned
- 2016-02-26 AU AU2016225052A patent/AU2016225052B2/en active Active
- 2016-02-26 EP EP16756485.5A patent/EP3261625A4/en active Pending
- 2016-02-26 CA CA2977540A patent/CA2977540C/en active Active
- 2016-02-26 JP JP2017563509A patent/JP2018506590A/ja active Pending
- 2016-02-26 KR KR1020177027388A patent/KR20170134409A/ko active Application Filing
- 2016-02-26 CN CN201680012546.6A patent/CN107530289A/zh active Pending
- 2016-02-26 MX MX2017011005A patent/MX2017011005A/es unknown
- 2016-02-26 KR KR1020237043973A patent/KR20240001281A/ko not_active Application Discontinuation
- 2016-02-26 WO PCT/US2016/019877 patent/WO2016138440A1/en active Application Filing
- 2016-02-26 BR BR112017018322A patent/BR112017018322A2/pt not_active Application Discontinuation
-
2017
- 2017-08-27 IL IL254159A patent/IL254159B2/en unknown
- 2017-12-22 US US15/852,168 patent/US20180185290A1/en not_active Abandoned
-
2018
- 2018-06-08 HK HK18107473.1A patent/HK1248102A1/zh unknown
-
2019
- 2019-11-12 US US16/681,261 patent/US20200146991A1/en not_active Abandoned
-
2020
- 2020-09-11 JP JP2020153173A patent/JP2021001190A/ja active Pending
-
2021
- 2021-10-07 AU AU2021245179A patent/AU2021245179B2/en active Active
-
2022
- 2022-08-25 US US17/822,226 patent/US20230121531A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20180185290A1 (en) | 2018-07-05 |
| CA2977540A1 (en) | 2016-09-01 |
| JP2021001190A (ja) | 2021-01-07 |
| BR112017018322A2 (pt) | 2018-04-17 |
| AU2021245179B2 (en) | 2024-03-07 |
| US20200146991A1 (en) | 2020-05-14 |
| KR20170134409A (ko) | 2017-12-06 |
| MX2017011005A (es) | 2018-01-16 |
| IL254159A0 (en) | 2017-10-31 |
| CN107530289A (zh) | 2018-01-02 |
| JP2018506590A (ja) | 2018-03-08 |
| IL254159B2 (en) | 2023-02-01 |
| AU2021245179A1 (en) | 2021-11-04 |
| KR20240001281A (ko) | 2024-01-03 |
| AU2016225052A1 (en) | 2017-09-21 |
| AU2016225052B2 (en) | 2021-07-08 |
| EP3261625A4 (en) | 2018-10-24 |
| WO2016138440A1 (en) | 2016-09-01 |
| EP3261625A1 (en) | 2018-01-03 |
| US20160250148A1 (en) | 2016-09-01 |
| IL254159B (en) | 2022-10-01 |
| CA2977540C (en) | 2023-10-03 |
| US20230121531A1 (en) | 2023-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL268697A (en) | Formulations | |
| FI3688162T3 (fi) | Formulaatioita | |
| IL265609A (en) | New formulations | |
| GB201607918D0 (en) | Novel formulations | |
| HK1258718A1 (zh) | 控釋製劑 | |
| IL254132A0 (en) | Solid preparation | |
| ZA201704263B (en) | Controlled-release formulations | |
| GB201419261D0 (en) | Formulations | |
| GB201419091D0 (en) | Formulations | |
| IL275735A (en) | Olanzapine sustained release pharmaceutical preparation | |
| HK1248102A1 (zh) | 三脈衝釋放興奮劑製劑 | |
| HK1252549A1 (zh) | 控釋tozadenant製劑 | |
| IL252955B (en) | Compounds for mouthwash | |
| GB201520724D0 (en) | Veterinary formulations | |
| GB201805338D0 (en) | Cosmetic formulations | |
| IL268195A (en) | Solid fosmetpantothenate formulations | |
| GB201621277D0 (en) | Formulations | |
| GB201714461D0 (en) | Formulations | |
| GB201618110D0 (en) | Formulations | |
| GB201616366D0 (en) | Formulations | |
| GB201615754D0 (en) | Formulations | |
| ZA201703472B (en) | Mouthrinse formulations | |
| GB201617866D0 (en) | Novel formulations | |
| GB201616509D0 (en) | Novel formulations | |
| GB201507784D0 (en) | Formulations |